Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Patterson

Showing results (111-120 of 204) with videos related to

Pageof 21
Sort By:
The Journal of Antimicrobial Chemotherapy|December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trialDimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin BTeclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases GroupRaoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 13, 2004
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancerSpencer W Redding, Marta C Dahiya, William R Kirkpatrick, et al.
Journal of Clinical Microbiology|December 23, 2011
Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detectionMartina Lengerova, Iva Kocmanova, Zdenek Racil, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosisNathan P Wiederhold, Laura K Najvar, Ana C Vallor, et al.
Journal of Clinical Microbiology|February 8, 2003
Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiationSpencer W Redding, William R Kirkpatrick, Stephen Saville, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2023
Erratum for Wiederhold et al., "The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate)"Nathan P Wiederhold, Thomas F Patterson, Sandra Rebholz, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 20, 2023
Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formationOlabayo H Ajetunmobi, Ashok K Chaturvedi, Hamid Badali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen TestingP Lewis White, John R Wingard, Stéphane Bretagne, et al.
Pageof 21

Showing results (111-120 of 204) with videos related to

Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trialDimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin BTeclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases GroupRaoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 13, 2004
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancerSpencer W Redding, Marta C Dahiya, William R Kirkpatrick, et al.
Journal of Clinical Microbiology|December 23, 2011
Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detectionMartina Lengerova, Iva Kocmanova, Zdenek Racil, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosisNathan P Wiederhold, Laura K Najvar, Ana C Vallor, et al.
Journal of Clinical Microbiology|February 8, 2003
Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiationSpencer W Redding, William R Kirkpatrick, Stephen Saville, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2023
Erratum for Wiederhold et al., "The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate)"Nathan P Wiederhold, Thomas F Patterson, Sandra Rebholz, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 20, 2023
Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formationOlabayo H Ajetunmobi, Ashok K Chaturvedi, Hamid Badali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen TestingP Lewis White, John R Wingard, Stéphane Bretagne, et al.
Pageof 21